Article thumbnail

Suppression of Cellular Transformation by Poly (A) Binding Protein Interacting Protein 2 (Paip2)

By Amy B. Rosenfeld


Controlling translation is crucial for the homeostasis of a cell. Its deregulation can facilitate the development and progression of many diseases including cancer. Poly (A) binding protein interacting protein 2 (Paip2) inhibits efficient initiation of translation by impairing formation of the necessary closed loop of mRNA. The over production of Paip2 in the presence of a constitutively active form of hRasV12 can reduce colony formation in a semi-solid matrix and focus formation on a cell monolayer. The ability of Paip2 to bind to Pabp is required to suppress the transformed phenotype mediated by hRasV12. These observations indicate that Paip2 is able to function as a tumor suppressor

Topics: Research Article
Publisher: Public Library of Science
OAI identifier:
Provided by: PubMed Central

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.

Suggested articles


  1. (2006). A mechanism of translational repression by competition of Paip2 with eIF4G for poly(A) binding protein (PABP) binding.
  2. (1998). A newly identified N-terminal amino acid sequence of human eIF4G binds poly(A)-binding protein and functions in poly(A)-dependent translation.
  3. (1998). Circularization of mRNA by eukaryotic translation initiation factors.
  4. (2000). Drosophila Cdk4 is required for normal growth and is dispensable for cell cycle progression.
  5. (2001). Dual interactions of the translational repressor Paip2 with poly(A) binding protein.
  6. (1993). Elevated levels of cyclin D1 protein in response to increased expression of eukaryotic initiation factor 4E.
  7. (1997). Gene expression profiles in normal and cancer cells.
  8. (2001). Genetic imbalances in preleukemic thymuses.
  9. (2003). Identification of novel ERK2 substrates through use of an engineered kinase and ATP analogs.
  10. (2000). Interaction of eIF4G with poly(A)-binding protein stimulates translation and is critical for Xenopus oocyte maturation.
  11. (1998). Interaction of polyadenylate-binding protein with the eIF4G homologue PAIP enhances translation.
  12. mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs.
  13. (2002). Paip1 interacts with poly(A) binding protein through two independent binding motifs.
  14. (1994). PHAS-I as a link between mitogen-activated protein kinase and translation initiation.
  15. (1992). Phosphorylation of translation initiation factor eIF-4E is induced in a ras-dependent manner during nerve growth factor-mediated PC12 cell differentiation.
  16. (2008). Poly(A)-binding protein-interacting protein 1 binds to eukaryotic translation initiation factor 3 to stimulate translation.
  17. (1996). Rapamycin blocks the phosphorylation of 4E-BP1 and inhibits cap-dependent initiation of translation.
  18. (1992). Ras mediates translation initiation factor 4E-induced malignant transformation.
  19. (1997). Structure of translation factor eIF4E bound to m7GDP and interaction with 4Ebinding protein.
  20. (2004). The Drosophila poly(A) binding protein-interacting protein, dPaip2, is a novel effector of cell growth.
  21. (2008). The E3 ubiquitin ligase EDD is an adverse prognostic factor for serous epithelial ovarian cancer and modulates cisplatin resistance in vitro.
  22. (1996). The eIF4E-binding proteins 1 and 2 are negative regulators of cell growth.
  23. (1992). The mRNA 59 cap-binding protein, eIF-4E, cooperates with v-myc or E1A in the transformation of primary rodent fibroblasts.
  24. (2008). Translational control of the innate immune response through IRF-7.
  25. (2001). Translational repression by a novel partner of human poly(A) binding protein,